Evaluation of the Analgesic Effect of Ropivacaine in Topical Use at the Thin Skin Graft Donor Site

NCT01999153 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Graft Pain

Interventions

DRUG: 20 mL topically used during alginate dressing NAROPEINE
DRUG: 20 mL topically used during alginate dressing NaCl

Sponsor

University Hospital, Rouen